Target genes and target cells in carcinogenesis

British Journal of Cancer

Volumn 80, Issue SUPPL. 1, 1999, Pages 28-33

  Frame, S ^a,c   Balmain, A ^b,c  

^a ONYX PHARMACEUTICALS   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; GROWTH FACTOR; PROTEIN P16; PROTEIN P53; RETINOBLASTOMA PROTEIN;

CANCER RESEARCH; CANCER RISK; CARCINOGENESIS; CELL CYCLE; CONFERENCE PAPER; GENE ACTIVITY; GENETIC PREDISPOSITION; HUMAN; MUTANT; NONHUMAN; ONCOGENE H RAS; PRIORITY JOURNAL; TARGET CELL;

ANIMALS; GENE TARGETING; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MUTATION; NEOPLASMS; NEOPLASMS, EXPERIMENTAL;

EID: 0032796982     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (58)

1. Aldaz CM, Trono T, Larcher F, Slaga TJ and Conti CJ (1980) Sequential trisomization of chromosomes 6 and 7 in mouse skin premalignant lesions. Mol Carcinogen 2: 22-26
2. Bailleul B, Surani MA, While S, Barton SC, Brown K, Blessing M, Jorcano J and Balmain A (1990) Skin hyperkeratosis and papilloma formation in transgenic mice expressing a ras oncogene from a suprabasal keratin promoter. Cell 62: 697-708
3. Baker SJ, Fearon ER, Nigro JM, Hamilton SR, Preisinger AC, Jessup JM, vanTuinen P, Ledbetter DH, Barker DF and Nakamura Y (1989) Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science 244: 217-221
4. Balmain A, and Pragnell IB (1983) Mouse skin carcinomas induced in vivo by chemical carcinogens have a transforming Harvey-ras oncogene. Nature 303: 72-74
5. Balmain A, Ramsden M, Bowden GT and Smith J (1984) Activation of the mouse cellular Harvey-ras gene in chemically induced benign skin papillomas. Nature 307: 658-660
6. Berenblum I and Shubik P (1947) A new, quantitative approach to the study of the stages of chemical carcinogenesis in the mouse's skin. Br J Cancer 1: 383-386
7. Bianchi AB, Fischer SM, Robles AI, Rinchik EM and Conti CJ (1993) Overexpression of cyclin D1 in mouse skin carcinogenesis. Oncogene 6: 439-444
8. Boveri T (1914) Zur Frage der Entstchung maligner Tumoren. Fishcher: Jena, Germany.
9. Brash DE, Rudolph JA, Simon JA, Lin A, McKeuna GJ, Baden HP, Halperin AJ and Ponten J (1991 ) A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci USA 88: 10124-10128
10. Brookes P (1966) Quantitative aspects of the reaction of some carcinogens with nucleic acids and the possible significance of such reactions in the process of carcinogenesis. Cancer Res 26: 1994-2003
11. Brown K, Quintanilla M, Ramsden M, Kerr IB, Young S and Balmain A (1986) v-ras genes from Harvey and BALB murine sarcoma viruses can act as initiators of two-stage mouse skin carcinogenesis. Cell 46: 447-456
12. Brown K, Buchmann A and Balmain A (1990) Carcinogen-induced mutations in the mouse c-Ha-ras gene provide evidence of multiple pathways for tumour progression. Proc Nat Acad Sci USA 87: 538-542
13. Brown K, Strathdee D, Bryson S, Lambic W and Balmain A (1998) The malignant capacity of skin tumours induced by expression of a mutant H-ras transgene depends on the cell type targeted. Curr Biol 8: 516-524
14. Buchmann A, Ruggeri A, Klein Szanto AJP and Balmain A (1991) Progression of squamous carcinoma cells to spindle carcinomas of mouse skin is associated with an imbalance of H-ras alleles on chromosome 7. Cancer Res 51: 4097-4101
15. Burns PA, Kemp CJ, Gannon JV, Lane DP, Bremner R and Balmain A (1991) Loss of heterozygosity and mutational alterations of the p53 gene in skin tumours of interspecific hybrid mice. Oncogene 6: 2363-2369
16. Cooper GM, Okenquist S and Silverman L (1980) Transforming activity of DNA of chemically transformed and normal cells. Nature 284: 418-421
17. Cotsarclis G, Sun TT, Lavker RM (1990)) Label-retaining cells reside in the bulge area of pilosebaceous unit: implications for follicular stem cells, hair cycle, and skin carcinogenesis, Cell 61: 1329-1337
18. Cui W, Fowlis DJ, Bryson S, Duffic E, Ireland H, Balmain A and Akhurst RJ (1996) TGFβ1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell 86: 531-542
19. Diaz Guerra M, Haddow S, Bauluz C, Jorcano JL, Cano A, Balmain A and Quintanilla M (1992) Expression of simple epithelial keratins in mouse epidermal keratmocytes harbouring Harvey-ras gene alterations, Cancer Res 52: 680-687
20. Filmus J, Robles AI, Shi W, Wong MJ, Colombo LL and Conti CJ (1994) Induction of cyclin DI overexpression by activated ras. Oncogene 9: 3627-3633
21. Greenhalgh DA, Wang XJ, Donehower LA and Balmain A (1996) Paradoxical tumour inhibitory effect of p53 loss in transgenic mice expressing epidermal targeted v-rasH, v-fos, or human transforming growth factor alpha. Cancer Rev 56: 4413-4423
22. Jouannean J, Tucker GC, Boyer B, Valles AM and Thiery JP (1991) Epithelial cell plasticity in neoplasia. Cancer Cells 3: 525-529
23. Kamijo T, Zindy F, Roussel MF, Quelle DE, Downing JR, Ashmun RA, Grosveld G, Sherr CJ (1997) Tumour suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 91: 649-659
24. Kemp CJ, Donehower LA, Bradley A and Balmain A (1993a) Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumours. Cell 74: 813-822
25. Kemp CJ, Fee F and Balmain A (1993b) Allelotype analysis of mouse skin tumours using polymorphic microsatellites: sequential genetic alterations on chromosomes 6, 7 and 11. Cancer Research 53: 6022-6027
26. Kemp CJ, Burns PA, Brown K, Nagase H and Balmain A (1994) Transgenic approaches to the analysis of ras and p53 function in multistage carcinogenesis, Cold Spring Harbor Symp Quant Biol 59: 427-431
27. INK4 and retinoblastoma protein status in non-small cell lung cancer: potential synergistic effect with altered p53 protein on proliferative activity. Cancer Res 56: 5557-5562
28. Klein-Szanto AJP, Larcher F, Bonfil RD and Conti CJ (1989) Multistage chemical carcinogencsis protocols produce spindle cell carcinomas of the mouse skin, Carcinogenesis 10: 2169-2172
29. Kretzschmar M, Massague J (1998) SMADs; mediators and regulators of TGF-beta signalling. Curr Opin Genet Dev 8: 103-111
30. Lammic GA, Fantl V, Smith R, Schuuring E, Brookes S, Michalides R, Dickson C, Arnold A and Peters G (1991) D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to bcl-1. Oncogene 6: 439-444
31. Lassus P, Ferlin M,Pietle J and Hibner U (1996) Anti-apoptotic activity of low levels of wild-type p53. EMBO J 15: 4566-4573
32. INK4b in undifferentiated mouse skin tumours. Cancer Res 55: 5168-5172
33. Loughran O, Edington KG, Berry IJ, Clark LJ and Parkinson EK (1994) Loss of heterozygosity of chromosome 9p21 is associated with the immorial phenotype of neoplastic human head and neck keratinocytes. Cancer Res 54: 5045-5049
34. MacCallum DE, Hupp TR, Midgley CA, Stuart D, Campbell SJ, Harper A, Walsh FS, Wright EG, Balmain A, Lane DP and Hall PA (1996) The p53 response to ionising radiation in adult and developing murine tissues. Oncogene 13: 2575-2587
35. Marshall CJ (1995) Specificity of receptor tyrosine kinase signalling: transient versus sustained extracellular signal regulated kinase activation. Cell 80: 179-185
36. Moen CJA, van der Valk MA, Snock M, van Zutphen BFM, Von Deimling O, Hart AAM and deMant P (1991) The recombinant congenic strains: a novel genetic tool applied to the study of colon tumour development in the mouse. Mammalian Genome 1: 217-227
37. Nagase H and Balmain A (1998) Cancer resistance genes in mice: models for the study of tumour modifiers, Trends Genet 14: 139-144
38. Nagase H, Bryson S, Cordell H, Kemp CJ, Fee F and Balmain A (1995) Cancer predisposition in mice: distinct loci control development of benign and malignant skin tumours, Nat Genet 10; 424-429
39. Nakazawa H, English D, Randell PL, Nakazawa K, Martel N, Armstrong BK and Yamnsaki H (1994) UV and skin cancer: specific p53 gene mutation in normal skin as a biologically relevant exposure measurement, Proc Natl Acad Sci USA 91: 360-364
40. Nataraj AJ, Black HS and Ananthaswanny HN (1996) Signature p53 mutation at DNA cross-linking sites in 8-methoxypsorale and ultraviolet A (PUVA)-induced murine skin cancers. Proc Natl Acad Sci USA 93: 7961-7965
41. Oft M, Peli J, Rudaz C, Schwarz H, Beug H and Reichmann F. (1996) TGFβ1 and Ha-ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumour cells. Genes Dev 10: 2462-2477
42. Ohgaki H, Hard GC, Hirota N, Mackawa A, Takahashi M and Kleihues p (1992) Selective mutation of codons 204 and 213 of the p53 gene in rat tumours induced by alkylating N-nitroso compounds. Cancer Res 52: 2995-2998
43. Ponder BA (1990) Inherited predisposition to cancer. Trends Genet 6: 213-218
44. Portella G, Cumming SA, Liddell J, Chi W, Ireland H, Akhurst RJ and Balmain A (1998) Transforming growth factor beta is essential for spindle cell conversion of mouse skin carcinoma in vivo; implications for tumour invasion. Cell Growth Differ 9: 393-404
45. Potten CS (1974) The epidermal proliferative unit: the possible role of the central basal cell. Cell Tissue Kinel 7: 77-88
46. Ouintanilla M, Brown K, Ramsden M and Balmain A (1986) Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis, Nature 322: 78-80
47. Reed JA, Loganzo FJr, Shea CR, Walker GJ, Flores JF, Glendening JM, Bogdany JK, Shiel MJ, Haluska FG and Fountain JW (1995) Loss of expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression, Cancer Res 55: 2713-2718
48. Roop DR, Lowy DR, Tambourin PE, Strickland J, Harper JR, Balaschak M, Spangler EF and Yuspa SH (1986) An activated Harvey ras oncogene produces benign tumours on mouse epidermal tissue. Nature 323: 822-824
49. Ruggeri B, DiRado M, Zhang SY, Bauer B, Goodrow T and Klein-Szanto AJ (1993) Benzo[a]pyrene-induced murine skin tumours exhibit frequent and characteristic G to T mutations in the p53 gene. Proc Natl Acad Sci USA 90: 1013-1017
50. Serrano M, Lee H, Chin L, Cordon-Cardo C, Beach D and DePinho RA (1996) Role of the INK4a locus in tumour suppression and cell mortality. Cell 85; 27-37
51. Shin C, Shilo B. Goldfarb MP, Dannenberg A and Weinberg RA (1979) Passage of phenotypes of chemically transformed cells via transfection of DNA and chromatin. Proc Natl Acad Sci USA 76: 5714-5718
52. Som T and Kolaparthi VSR (1994) Developmental decisions in Aspergillus nidulans are modulated by ras activity, Mol Cell Biol 14: 5333-5348
53. Van Duuren BL, Sivak A, Katz C, Seidman I and Melchionine S (1975) The effect of aging and interval between primary and secondary treatment in two-stage carcinogenesis in mouse skin. Cancer Res 35: 502-505
54. Whitman M and Melton DA (1992) Involvement of p21 ras in Xenopus mesoderm induction. Nature 357: 252-254
55. Yoo GH, Xu HJ, Brennan JA, Westra W, Hruban RH, Koch W, Benedict WF and Sidransky D (1994) Infrequent inactivation of the retinoblastoma gene despite frequent loss of chromosome 13q in head and neck squamous cell carcinoma. Cancer Res 54: 4603-4606
56. Yuspa SH (1994) The pathogenesis of squamous cell cancer: lessons learned from studies of skin carcinogenesis. Thirty-third GHA Clowes Memorial Award Lecture. Cancer Res 54: 1178-1189
57. Zarbl H, Sukumar S, Arthur AV, Martin-Zanca D and Barbacid M (1985) Direct mutagenesis of Ha-ras-1 oncogenes by N-nitroso-N-methylurca during initiation of mammary carcinogenesis in rats. Nature 315: 382-385
58. Ziegler A M, Leffell DJ, Kunala S, Sharma HW, Gailani M, Simon JA, Halperin AJ, Baden HP, Shapiro PE, Bale AE and Brash DE (1993) Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers. Proc Natl Acad Sci USA 90: 4216-4220